STARSOURCE.BO · BSE
STARSOURCE MULTITRADE LIMITED
₹73.45
+0.01% (+₹0.01)
Prev. close
₹73.44
Volume
526
As of
18 Sept 2026
Price history
No analyst calls on this stock in the last 90 days yet.
Explore by date range →Analyst opinions
Fundamentals
About STARSOURCE MULTITRADE LIMITED
Starsource Multitrade Limited does not have significant operations. The company was previously engaged in the production of pharmaceutical and bulk drug products. The company was formerly known as Chemo Pharma Laboratories Limited and changed its name to Starsource Multitrade Limited in October 2025. The company was incorporated in 1942 and is based in Mumbai, India.
Details
Sector
Healthcare
Industry
Biotechnology
CEO
Mr. Ruchit Mehta
Headquarters
Ahmedabad
Website
starsourcemultitrade.comExchange
View on BSE ↗Key stats
Market cap
₹11.02 Cr
EPS (TTM)
₹-0.19
Beta (1Y · daily vs NIFTY 50)
-0.09
Beta (5Y · monthly vs NIFTY 50)
-0.15
Shares float
8.48 L
EPS · quarter ended Jun 2026
₹0.14
Financial Performance
01 · Financials
02 · Earnings Per Share (EPS)
04 · Operating Efficiency (Growth Rates)
Balance-sheet-based · pre-FY23 not filed in verifiable form
05 · Capital Structure & Asset Utilization
Pre-FY23 not filed in verifiable form
Asset turnover needs a prior year of assets — omitted for the earliest available year.
06 · Asset Base Composition
Pre-FY23 not filed in verifiable form
07 · Debt Level & Coverage
Pre-FY23 not filed in verifiable form
08 · Profit & Loss
Annual
| Line item | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|
| ₹0 | ₹0 | ₹0 | ₹52.60 L | |
| EBITDA | ₹9.71 L | ₹1.65 Cr | ₹50.35 L | ₹-11.85 Cr |
| ₹4.73 L | ₹1.20 Cr | ₹34.22 L | ₹-11.86 Cr | |
| Diluted EPS | ₹0.32 | ₹8 | ₹2.28 | ₹-79.03 |
Total expenses (as filed), Employee benefit expense, Other expenses have filed figures for only some of the years shown — the missing years are left blank rather than estimated.
09 · Balance Sheet
Annual
| Line item | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|
| ₹11.62 Cr | ₹13.02 Cr | ₹13.35 Cr | ₹1.81 Cr | |
| — | — | ₹0 | ₹0 | |
| Stockholders' equity | ₹11.60 Cr | ₹12.80 Cr | ₹13.14 Cr | ₹1.29 Cr |
Trade receivables, Total debt, Long-term debt, Current (short-term) debt, Others have filed figures for only some of the years shown — the missing years are left blank rather than estimated.
Annual only — the data source doesn’t publish quarterly balance-sheet detail for most NSE-listed companies.
10 · Cash Flow Statement
Annual
| Line item | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|
| ₹-68.34 L | ₹72.36 L | ₹-28.25 L | ₹-10.62 Cr | |
| Investing cash flow | ₹62.97 L | ₹-52.48 L | ₹10.46 Cr | ₹1.10 L |
| Financing cash flow | ₹-7.63 L | ₹-14.89 L | ₹-15.86 L | ₹0 |
| End cash position | ₹55.59 L | ₹60.58 L | ₹10.62 Cr | ₹1.22 L |
Annual only — the data source has no quarterly cash-flow-statement coverage.
12 · Peer Comparison
Healthcare
| Company | ||||||||
|---|---|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Limited | ₹4.48 L Cr | ₹1,837.3 | 37.0 | 5.36 | 13.7% | 0.06 | +11.9% | +11.4% |
| Divi's Laboratories Limited | ₹2.47 L Cr | ₹9,375 | 83.3 | 14.77 | 15.3% | 0.00 | +12.3% | +53.4% |
| Torrent Pharmaceuticals Limited | ₹1.83 L Cr | ₹4,875 | 76.9 | 21.82 | 25.8% | 1.79 | +21.5% | +37.4% |
| Apollo Hospitals Enterprise Limited | ₹1.26 L Cr | ₹8,944.5 | 60.4 | 13.30 | 20.5% | 0.90 | +15.7% | +13.9% |
| Lenskart Solutions Limited | ₹1.18 L Cr | ₹707.2 | 179.9 | 13.48 | 5.6% | 0.35 | +35.4% | — |
| Zydus Lifesciences Limited | ₹1.13 L Cr | ₹1,160 | 25.3 | 4.18 | 18.6% | 0.46 | +18.4% | +10.7% |
| Cipla Limited | ₹1.10 L Cr | ₹1,376.3 | 32.5 | 3.19 | 11.3% | 0.02 | +2.1% | -11.8% |
| Laurus Labs Limited | ₹1.05 L Cr | ₹1,954 | 96.4 | 19.86 | 16.8% | 0.48 | +22.0% | +111.6% |
| Max Healthcare Institute Limited | ₹1.01 L Cr | ₹1,049.3 | 69.8 | 9.39 | 13.4% | 0.32 | +19.0% | -10.6% |
| Dr. Reddy's Laboratories Limited | ₹97,876.16 Cr | ₹1,185 | 29.6 | 2.60 | 11.4% | 0.21 | +3.2% | -10.4% |
| Manipal Health Enterprises Limited | ₹97,364.22 Cr | ₹738.95 | 146.6 | 11.56 | 7.8% | 1.53 | +18.0% | — |
| STARSOURCE MULTITRADE LIMITED | ₹11.02 Cr | ₹73.44 | — | 8.54 | -919.2% | 0.00 | — | — |
Ranked by market cap within Healthcare, same metrics as the Fundamentals screener. Click a column to sort.
Documents
Annual reports
Show all 24
Official documents linked from their sources — offer documents as filed with SEBI (sebi.gov.in), annual reports and earnings-call transcripts as published on BSE (bseindia.com) and NSE (nseindia.com). Links open the source's own hosting; nothing is re-hosted here.